Detail akcie IDEXX Labs online

Business Summary: IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, IDEXX Laboratories, Inc. revenues increased 9% to $3.66B. Net income increased 24% to $845M. Revenues reflect CAG segment increase of 10% to $6.29B, Water segment increase of 8% to $168.1M, United States segment increase of 10% to $2.39B, Other Euorpe segment increase of 9% to $176.4M, France segment increase of 15% to $96.8M. Net income benefited from CAG segment income increase of 26% to $1.01B.